VOYA Investment Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-24,520
Closed -$591K 3070
2023
Q1
$591K Hold
24,520
﹤0.01% 1953
2022
Q4
$259K Hold
24,520
﹤0.01% 2425
2022
Q3
$110K Buy
24,520
+2,438
+11% +$11.1K ﹤0.01% 2754
2022
Q2
$88K Hold
22,082
﹤0.01% 2646
2022
Q1
$162K Hold
22,082
﹤0.01% 2424
2021
Q4
$124K Sell
22,082
-143
-0.6% -$908 ﹤0.01% 2633
2021
Q3
$142K Hold
22,225
﹤0.01% 2663
2021
Q2
$187K Hold
22,225
﹤0.01% 2631
2021
Q1
$233K Buy
22,225
+1,494
+7% +$21K ﹤0.01% 2451
2020
Q4
$351K Buy
20,731
+5,323
+35% +$79.8K ﹤0.01% 2120
2020
Q3
$198K Buy
15,408
+819
+6% +$10.3K ﹤0.01% 2159
2020
Q2
$206K Buy
+14,589
New +$184K ﹤0.01% 2135

Other funds holding PRVB

VOYA Investment Management's PRVB Position: Q2 2023 in Review

VOYA Investment Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 24,520 shares — an estimated $591K sold.

VOYA Investment Management first reported a position in PRVB in Q2 2020 and held it in 12 quarters. The position peaked at $591K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • VOYA Investment Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • VOYA Investment Management sold 24,520 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $591K.
  • VOYA Investment Management first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • VOYA Investment Management's Provention Bio, Inc. Common Stock position peaked at $591K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.